RIGEL PHARMACEUTICALS INC (RIGL)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RIGL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RIGL | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NEO | Director; Board Member and Chair of the Compliance Committee | 64 | ["Over 30 years' experience in the development of investigational cancer chemotherapies","Consultant to the pharmaceutical industry for over 20 years","Senior Vice President and Chief Medical Officer at CytomX Therapeutics from 2020 to 2022","Former Senior Medical Director at SUGEN and Quintiles","Specializes in clinical development strategy","Filed over 30 Investigational New Drug applications","Fellow with the Royal Society of Medicine","Significant healthcare knowledge in oncology drug development"] | ["Audit and Finance Committee","Culture and Compensation Committee","Innovation, Pipeline & Technology Committee","Compliance Committee"] | 2025 |